Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-43,081
Closed -$19.5K 1672
2025
Q2
$19.5K Hold
43,081
﹤0.01% 1260
2025
Q1
$17.5K Hold
43,081
﹤0.01% 1245
2024
Q4
$28.5K Hold
43,081
﹤0.01% 1063
2024
Q3
$36.6K Hold
43,081
﹤0.01% 1089
2024
Q2
$28.7K Hold
43,081
﹤0.01% 961
2024
Q1
$56K Buy
+43,081
New +$45.1K ﹤0.01% 978
2023
Q4
Sell
-31,240
Closed -$23.6K 1146
2023
Q3
$23.6K Hold
31,240
﹤0.01% 770
2023
Q2
$22.8K Buy
+31,240
New +$29K ﹤0.01% 712
2014
Q2
Sell
-2,720
Closed -$182K 569
2014
Q1
$182K Buy
+2,720
New +$168K 0.03% 235

Other funds holding VXRT

LMR Partners's VXRT Position: Q3 2025 in Review

LMR Partners sold out of Vaxart (VXRT) in Q3 2025, closing a stake of 43,081 shares — an estimated $19.5K sold.

LMR Partners first reported a position in VXRT in Q1 2014 and held it in 9 quarters. The position peaked at $182K in Q1 2014. 17 funds tracked by Wall St. Rank hold VXRT as of Q3 2025.

  • LMR Partners reported no remaining Vaxart position as of Q3 2025 after selling out during the quarter.
  • LMR Partners sold 43,081 Vaxart shares in Q3 2025, an estimated $19.5K.
  • LMR Partners first reported a position in Vaxart in Q1 2014 and held it in 9 quarters.
  • LMR Partners's Vaxart position peaked at $182K in Q1 2014.
  • 17 funds tracked by Wall St. Rank held Vaxart as of Q3 2025.

Based on LMR Partners's 13F filing for Q3 2025, filed 14 Nov 2025.